“…Currently,types 16,18,31,33,35,39,45,51,52,56,58, as low-risk types; and types 26, 53 and 66 considered as probably oncogenic (Burnett-Hartman et al, 2008;Yahyapour et al, 2013). The oncogenic potential of HPV is related to its ability to interfere, upon viral integration into the host cell DNA, with the cell cycle and tumor supportive function of the p53 and pRB proteins (Giuliani et al, 2008).…”